Previous Article | Next Article 
Journal of Virology, December 2007, p. 13112-13124, Vol. 81, No. 23
0022-538X/07/$08.00+0 doi:10.1128/JVI.00892-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
7SL RNA Mediates Virion Packaging of the Antiviral Cytidine Deaminase APOBEC3G
Tao Wang,1,
Chunjuan Tian,1,3,
Wenyan Zhang,1,3,
Kun Luo,1
Phuong Thi Nguyen Sarkis,1
Lillian Yu,1
Bindong Liu,1
Yunkai Yu,1 and
Xiao-Fang Yu1,2*
Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205,1
Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang, China,2
Jilin University, Changchun, China3
Received 26 April 2007/
Accepted 11 September 2007
Cytidine deaminase APOBEC3G (A3G) has broad antiviral activity against diverse retroviruses and/or retrotransposons, and its antiviral functions are believed to rely on its encapsidation into virions in an RNA-dependent fashion. However, the cofactors of A3G virion packaging have not yet been identified. We demonstrate here that A3G selectively interacts with certain polymerase III (Pol III)-derived RNAs, including Y3 and 7SL RNAs. Among A3G-binding Pol III-derived RNAs, 7SL RNA was preferentially packaged into human immunodeficiency virus type 1 (HIV-1) particles. Efficient packaging of 7SL RNA, as well as A3G, was mediated by the RNA-binding nucleocapsid domain of HIV-1 Gag. A3G mutants that had reduced 7SL RNA binding but maintained wild-type levels of mRNA and tRNA binding were packaged poorly and had impaired antiviral activity. Reducing 7SL RNA packaging by overexpression of SRP19 proteins inhibited 7SL RNA and A3G virion packaging and impaired its antiviral function. Thus, 7SL RNA that is encapsidated into diverse retroviruses is a key cofactor of the antiviral A3G. This selective interaction of A3G with certain Pol III-derived RNAs raises the question of whether A3G and its cofactors may have as-yet-unidentified cellular functions.
* Corresponding author. Mailing address: Department of Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, MD 21205. Phone: (410) 955-3768. Fax: (410) 614-8263. E-mail:
xfyu{at}jhsph.edu
Published ahead of print on 19 September 2007.
T.W., C.T., and W.Z. contributed equally to this study.
Journal of Virology, December 2007, p. 13112-13124, Vol. 81, No. 23
0022-538X/07/$08.00+0 doi:10.1128/JVI.00892-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Bulliard, Y., Turelli, P., Rohrig, U. F., Zoete, V., Mangeat, B., Michielin, O., Trono, D.
(2009). Functional Analysis and Structural Modeling of Human APOBEC3G Reveal the Role of Evolutionarily Conserved Elements in the Inhibition of Human Immunodeficiency Virus Type 1 Infection and Alu Transposition. J. Virol.
83: 12611-12621
[Abstract]
[Full Text]
-
Chen, G., He, Z., Wang, T., Xu, R., Yu, X.-F.
(2009). A Patch of Positively Charged Amino Acids Surrounding the Human Immunodeficiency Virus Type 1 Vif SLVx4Yx9Y Motif Influences Its Interaction with APOBEC3G. J. Virol.
83: 8674-8682
[Abstract]
[Full Text]
-
Stauch, B., Hofmann, H., Perkovic, M., Weisel, M., Kopietz, F., Cichutek, K., Munk, C., Schneider, G.
(2009). Model structure of APOBEC3C reveals a binding pocket modulating ribonucleic acid interaction required for encapsidation. Proc. Natl. Acad. Sci. USA
106: 12079-12084
[Abstract]
[Full Text]
-
Henriet, S., Mercenne, G., Bernacchi, S., Paillart, J.-C., Marquet, R.
(2009). Tumultuous Relationship between the Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) and the Human APOBEC-3G and APOBEC-3F Restriction Factors. Microbiol. Mol. Biol. Rev.
73: 211-232
[Abstract]
[Full Text]
-
Malim, M. H
(2009). APOBEC proteins and intrinsic resistance to HIV-1 infection. Phil Trans R Soc B
364: 675-687
[Abstract]
[Full Text]
-
Khatua, A. K., Taylor, H. E., Hildreth, J. E. K., Popik, W.
(2009). Exosomes Packaging APOBEC3G Confer Human Immunodeficiency Virus Resistance to Recipient Cells. J. Virol.
83: 512-521
[Abstract]
[Full Text]
-
Watashi, K., Khan, M., Yedavalli, V. R. K., Yeung, M. L., Strebel, K., Jeang, K.-T.
(2008). Human Immunodeficiency Virus Type 1 Replication and Regulation of APOBEC3G by Peptidyl Prolyl Isomerase Pin1. J. Virol.
82: 9928-9936
[Abstract]
[Full Text]
-
Nguyen, D. H., Hu, J.
(2008). Reverse Transcriptase- and RNA Packaging Signal-Dependent Incorporation of APOBEC3G into Hepatitis B Virus Nucleocapsids. J. Virol.
82: 6852-6861
[Abstract]
[Full Text]
-
Bogerd, H. P., Cullen, B. R.
(2008). Single-stranded RNA facilitates nucleocapsid: APOBEC3G complex formation. RNA
14: 1228-1236
[Abstract]
[Full Text]
-
Gallois-Montbrun, S., Holmes, R. K., Swanson, C. M., Fernandez-Ocana, M., Byers, H. L., Ward, M. A., Malim, M. H.
(2008). Comparison of Cellular Ribonucleoprotein Complexes Associated with the APOBEC3F and APOBEC3G Antiviral Proteins. J. Virol.
82: 5636-5642
[Abstract]
[Full Text]
-
Langlois, M.-A., Neuberger, M. S.
(2008). Human APOBEC3G Can Restrict Retroviral Infection in Avian Cells and Acts Independently of both UNG and SMUG1. J. Virol.
82: 4660-4664
[Abstract]
[Full Text]
-
Mulder, L. C. F., Harari, A., Simon, V.
(2008). Cytidine deamination induced HIV-1 drug resistance. Proc. Natl. Acad. Sci. USA
105: 5501-5506
[Abstract]
[Full Text]